Skip to main content

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
Cancel
×
×
Home
  • Home
Article
  • Cited by 43
  • Cited by
    Crossref Citations
    Crossref logo
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.
    Sundström, Kristian 2018. Cost of Illness for Five Major Foodborne Illnesses and Sequelae in Sweden. Applied Health Economics and Health Policy, Vol. 16, Issue. 2, p. 243.
    BABO MARTINS, S. RUSHTON, J. and STÄRK, K. D. C. 2017. Economics of zoonoses surveillance in a ‘One Health’ context: an assessment of Campylobacter surveillance in Switzerland. Epidemiology and Infection, Vol. 145, Issue. 06, p. 1148.
    Devleesschauwer, Brecht Bouwknegt, Martijn Mangen, Marie-Josée J. and Havelaar, Arie H. 2017. Campylobacter. p. 27.
    SCHMUTZ, C. MÄUSEZAHL, D. BLESS, P. J. HATZ, C. SCHWENKGLENKS, M. and URBINELLO, D. 2017. Estimating healthcare costs of acute gastroenteritis and human campylobacteriosis in Switzerland. Epidemiology and Infection, Vol. 145, Issue. 04, p. 627.
    Cady, Nathaniel C. Fusco, Vincenzina Maruccio, Giuseppe Primiceri, Elisabetta and Batt, Carl A. 2017. Nanobiosensors. p. 475.
    Stephen, Dimity Maree and Barnett, Adrian Gerard 2017. Using Microsimulation to Estimate the Future Health and Economic Costs of Salmonellosis under Climate Change in Central Queensland, Australia. Environmental Health Perspectives, Vol. 125, Issue. 12,
    Maertens de Noordhout, Charline Devleesschauwer, Brecht Haagsma, Juanita A Havelaar, Arie H Bertrand, Sophie Vandenberg, Olivier Quoilin, Sophie Brandt, Patrick T and Speybroeck, Niko 2017. Burden of salmonellosis, campylobacteriosis and listeriosis: a time series analysis, Belgium, 2012 to 2020. Eurosurveillance, Vol. 22, Issue. 38,
    Cassini, A Colzani, E Kramarz, P Kretzschmar, ME and Takkinen, J 2016. Impact of food and water-borne diseases on European population health. Current Opinion in Food Science, Vol. 12, Issue. , p. 21.
    Suijkerbuijk, Anita W.M. Bouwknegt, Martijn Mangen, Marie-Josee J. de Wit, G. Ardine van Pelt, Wilfrid Bijkerk, Paul and Friesema, Ingrid H.M. 2016. The economic burden of aSalmonellaThompson outbreak caused by smoked salmon in the Netherlands, 2012–2013. The European Journal of Public Health, p. ckw205.
    Connor, Bradley A. 2016. Post-Infectious Sequelae of Travelers’ Diarrhea: Reactive Arthritis, Guillain-Barré Syndrome, and Irritable Bowel Syndrome. Current Tropical Medicine Reports, Vol. 3, Issue. 3, p. 102.
    Radomska, Katarzyna A. Vaezirad, Mahdi M. Verstappen, Koen M. Wösten, Marc M. S. M. Wagenaar, Jaap A. van Putten, Jos P. M. and Cao, Yongchang 2016. Chicken Immune Response after In Ovo Immunization with Chimeric TLR5 Activating Flagellin of Campylobacter jejuni. PLOS ONE, Vol. 11, Issue. 10, p. e0164837.
    Mangen, Marie-Josée J. Bouwknegt, Martijn Friesema, Ingrid H.M. Haagsma, Juanita A. Kortbeek, Laetitia M. Tariq, Luqman Wilson, Margaret van Pelt, Wilfrid and Havelaar, Arie H. 2015. Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011. International Journal of Food Microbiology, Vol. 196, Issue. , p. 84.
    Porter, Chad K. Thura, Nadia Schlett, Carey D. Sanders, John W. Tribble, David R. Monteville, Marshall R. and Riddle, Mark S. 2015. Establishment of Health Utility Indices for Post-Infectious Functional Gastrointestinal Disorders in Active Duty Us Military. Journal of Travel Medicine, Vol. 22, Issue. 4, p. 237.
    SCALLAN, E. HOEKSTRA, R. M. MAHON, B. E. JONES, T. F. and GRIFFIN, P. M. 2015. An assessment of the human health impact of seven leading foodborne pathogens in the United States using disability adjusted life years. Epidemiology and Infection, Vol. 143, Issue. 13, p. 2795.
    Devleesschauwer, Brecht Haagsma, Juanita A. Angulo, Frederick J. Bellinger, David C. Cole, Dana Döpfer, Dörte Fazil, Aamir Fèvre, Eric M. Gibb, Herman J. Hald, Tine Kirk, Martyn D. Lake, Robin J. Maertens de Noordhout, Charline Mathers, Colin D. McDonald, Scott A. Pires, Sara M. Speybroeck, Niko Thomas, M. Kate Torgerson, Paul R. Wu, Felicia Havelaar, Arie H. Praet, Nicolas and Kretzschmar, Mirjam E. E. 2015. Methodological Framework for World Health Organization Estimates of the Global Burden of Foodborne Disease. PLOS ONE, Vol. 10, Issue. 12, p. e0142498.
    Havelaar, Arie H. Kirk, Martyn D. Torgerson, Paul R. Gibb, Herman J. Hald, Tine Lake, Robin J. Praet, Nicolas Bellinger, David C. de Silva, Nilanthi R. Gargouri, Neyla Speybroeck, Niko Cawthorne, Amy Mathers, Colin Stein, Claudia Angulo, Frederick J. Devleesschauwer, Brecht and von Seidlein, Lorenz 2015. World Health Organization Global Estimates and Regional Comparisons of the Burden of Foodborne Disease in 2010. PLOS Medicine, Vol. 12, Issue. 12, p. e1001923.
    Lake, R.J. Stein, C.E. and Havelaar, A.H. 2014. Encyclopedia of Food Safety. p. 73.
    Schmulson, M. Bielsa, M.V. Carmona-Sánchez, R. Hernández, A. López-Colombo, A. López Vidal, Y. Peláez-Luna, M. Remes-Troche, J.M. Tamayo, J.L. and Valdovinos, M.A. 2014. Microbiota, infecciones gastrointestinales, inflamación de bajo grado y antibioticoterapia en el síndrome de intestino irritable. Una revisión basada en evidencias. Revista de Gastroenterología de México, Vol. 79, Issue. 2, p. 96.
    Marin, Clara Palomeque, Maria-Dolores Marco-Jiménez, Francisco Vega, Santiago and Cloeckaert, Axel 2014. Wild Griffon Vultures (Gyps fulvus) as a Source of Salmonella and Campylobacter in Eastern Spain. PLoS ONE, Vol. 9, Issue. 4, p. e94191.
    Sundström, Kristian Wahlström, Helene Ivarsson, Sofie Sternberg Lewerin, Susanna and Kirk, Martyn 2014. Economic Effects of Introducing Alternative Salmonella Control Strategies in Sweden. PLoS ONE, Vol. 9, Issue. 5, p. e96446.
    Download full list
    ×
  • Get access
    Add to cart USD35.00
    Check if you have access via personal or institutional login
    Log in Register Recommend to librarian

Disease burden of post-infectious irritable bowel syndrome in The Netherlands

  • J. A. HAAGSMA (a1) (a2), P. D. SIERSEMA (a3), N. J. DE WIT (a4) and A. H. HAVELAAR (a1) (a5)
Summary

Post-infectious irritable bowel syndrome (PI-IBS) has been established as a sequel of infectious intestinal disease (IID). The aim of this study was to estimate the burden of PI-IBS caused by the pathogens Campylobacter, Salmonella and Shigella, and to compare this with other outcomes associated with these pathogens. The attributable risk of PI-IBS due to bacterial pathogens was calculated and linked to national data on gastroenteritis incidence and measures for severity and duration of illness in order to estimate the burden of PI-IBS. One year post-infection, IBS developed in 9% of patients with bacterial IID. The burden of PI-IBS adds over 2300 disability adjusted life years to the total annual disease burden for the selected pathogens. PI-IBS is a frequent sequel of IID, resulting in a considerable disease burden compared to other outcomes. If this relationship is not considered, this will result in an underestimation of the disease burden of IID.

Copyright
COPYRIGHT: © Cambridge University Press 2010
Corresponding author
*Author for correspondence: J. A. Haagsma, M.Sc., National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Laboratory for Zoonoses and Environmental Microbiology, P.O. Box 1, 3720 BA Bilthoven, The Netherlands. (Email: j.haagsma@erasmusmc.nl)
References
Hide All
1.Murray, CJL, Lopez, AD (eds). The global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press, 1996.
2.Kemmeren, JM, et al. Priority setting of foodborne pathogens. Disease burden and costs of selected enteric pathogens. Bilthoven, The Netherlands: National Institute of Public Health and the Environment, 2006.
3.Cressey, P, Lake, R. Risk ranking: estimates of the burden of foodborne disease for New Zealand. Christchurch, New Zealand: ESR, 2007.
4.Havelaar, AH, et al. Health burden in the Netherlands due to infection with thermophilic Campylobacter spp. Epidemiology and Infection 2000; 125: 505–522.
5.Hungin, AP, et al. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Alimentary Pharmacology & Therapeutics 2003; 17: 643–650.
6.Mertz, HR. Irritable bowel syndrome. New England Journal of Medicine 2003; 349: 2136–2146.
7.DuPont, AW. Postinfectious irritable bowel syndrome. Clinical Infectious Diseases 2008; 46: 594–599.
8.Halvorson, HA, Schlett, CD, Riddle, MS. Postinfectious irritable bowel syndrome – a meta-analysis. American Journal of Gastroenterology 2006; 101: 1894–1899.
9.Smith, JL, Bayles, D. Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis. Journal of Food Protection 2007; 70: 1762–1769.
10.Spiller, RC. Role of infection in irritable bowel syndrome. Journal of Gastroenterology 2007; 42: S41–S47.
11.Thabane, M, Kottachchi, DT, Marshall, JK. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 2007; 26: 535–544.
12.Glia, A, Lindberg, G. Quality of life in patients with different types of functional constipation. Scandinavian Journal of Gastroenterology 1997; 32: 1083–1089.
13.Pare, P, et al. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Clinical Therapeutics 2006; 28: 1726–1735.
14.Jung, IS, et al. The clinical course of postinfectious irritable bowel syndrome: a five-year follow-up study. Journal of Clinical Gastroenterology 2009; 43: 534–540.
15.Ji, S, et al. Post-infectious irritable bowel syndrome in patients with Shigella infection. Journal of Gastroenterology and Hepatology 2005; 20: 381–386.
16.Kim, HS, et al. The development of irritable bowel syndrome after Shigella infection: 3 year follow-up study. Korean Journal of Gastroenterology 2006; 47: 300–305.
17.DuPont, HL. Systematic review: prevention of travellers' diarrhoea. Alimentary Pharmacology & Therapeutics 2008; 27: 741–751.
18.Vose, D. Risk Analysis: A Quantative Guide. Chichester: John Wiley and Sons, 2000.
19.Havelaar, AH, et al. Disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157. Epidemiology and Infection 2004; 132: 467–484.
20.de Wit, MA, et al. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. American Journal of Epidemiology 2001; 154: 666–674.
21.Janssen, MF, Birnie, E, Bonsel, G. Feasibility and reliability of the annual profile method for deriving QALYs for short-term health conditions. Medical Decision Making 2008; 28: 500–510.
22.Gwee, KA, et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996; 347: 150–153.
23.Marshall, JK, et al. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clinical Gastroenterology and Hepatology 2007; 5: 457–460.
24.McKeown, ES, et al. Postinfectious irritable bowel syndrome may occur after non-gastrointestinal and intestinal infection. Neurogastroenterology and Motility 2006; 18: 839–843.
25.Neal, KR, Barker, L, Spiller, RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut 2002; 51: 410–413.
26.Rodriguez, LA, Ruigomez, A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. British Medical Journal 1999; 318: 565–566.
27.Parry, SD, et al. Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. American Journal of Gastroenterology 2003; 98: 1970–1975.
28.Fisher, LD, van Belle, G. Biostatistics: A Methodology for the Health Sciences. New York: John Wiley and Sons, 1993.
29.Spiller, R, Garsed, K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979–1988.
30.Crowell, MD, et al. Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function. Current Opinion in Investigational Drugs 2004; 5: 55–60.
31.Dunlop, SP, et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clinical Gastroenterology and Hepatology 2005; 3: 349–357.
32.Houghton, LA, Foster, JM, Whorwell, PJ. Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers. Alimentary Pharmacology & Therapeutics 2000; 14: 775–782.
33.Doorduyn, Y, et al. Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases. Epidemiology and Infection 2008; 136: 1225–1234.
34.Mearin, F, et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005; 129: 98–104.
35.Neal, KR, Hebden, J, Spiller, R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. British Medical Journal 1997; 314: 779–782.
36.Cuomo, R, Savarese, MF, Gargano, R. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: consensus issues. Digestive Diseases 2007; 25: 241–244.
37.Wang, LH, Fang, XC, Pan, GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004; 53: 1096–1101.
38.Bijkerk, CJ, et al. Randomized patients in IBS research had different disease characteristics compared to eligible and recruited patients. Journal of Clinical Epidemiology 2008; 61: 1176–1181.
39.Brazier, J, et al. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics 2004; 13: 873–884.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *

CAPTCHA *

Skip to the audio challenge
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 7
Total number of PDF views: 32 *
Loading metrics...

Abstract views

Total abstract views: 262 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 13th June 2018. This data will be updated every 24 hours.

Cancel
Confirm
×